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Abstract
IDENTIFICATION OF APOPTOSIS PATHWAY IN TREACHER COLLINS 
SYNDROME
By Khaled Alsayegh, B.S
A Thesis submitted in partial fulfillment of the requirements for the degree of Master of 
Science at Virginia Commonwealth University.
Virginia Commonwealth University, 2009
Major Director:  Rita Shiang
Associate Professor, Department of Human & Molecular Genetics
Treacher  Collins  Syndrome  (TCS)  is  a  rare  autosomal  dominant  disorder 
characterized by severe craniofacial defects. The syndrome is associated with mutations in 
the  TCOF1  gene,  which  encodes  a  nucleolar  phosphoprotein  called  treacle.  Model 
organisms have been generated to model the disease and have revealed knowledge about 
the etiology and pathogenesis of the disorder. The craniofacial abnormality observed in 
TCS  patients  is  found  to  be  caused  by  an  increased  level  of  apoptosis  in  the 
neuroepithelium and from this it has been suggested that treacle is important for proper 
formation and proliferation of neural crest cells that will ultimately contribute to the face. 
The best attempt to rescue the phenotype of TCS was made by inhibiting the expression of 
p53 in both zebrafish and mouse models. Although both rescues were successful, it resulted 
in  tumor  formation in  mice which  limits  the potential  of  using this  type of  rescue in 
humans. Therefore, it is very important to identify p53-downstream genes that were not 
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related to cancer and use them to interrupt the apoptosis pathway and hence rescuing the 
phenotype.  
6
CHAPTER 1: Neural Crest Cells and Craniofacial Development
History of Neural Crest Cells
“What role these cells play in the formation of later tissues I do not know, nor do I know 
what becomes of the “lost” portions of the neural crest which lie between the spinal  
ganglia, but it has become evident that the whole question of the nature of “mesoderm” in 
Vertebrates needs revision founded on fact rather than theory.”
—J. B. Platt, 1893
Neural crest cells were first called Zwischenstrang, which meant the intermediate 
cord,  when  the  Swiss  embryologist,  Wilhelm  His,  identified  these  cells  sandwiched 
between the epidermal ectoderm and the neural tube in the neurula stage chick embryos. 
The neural crest was first named by Arthur Milnes Marshall. (Hall, 1999).
In the early 1890’s, neural crest cells were still thought to have only been the source 
of neurons and ganglia. But in 1897, Julia Platt showed that the cartilages of the head and 
face and the cells that formed the teeth, originate from neural crest cells (Platt et al., 1897). 
This was shown in the mud puppy, Necturus.
The number of tissues that the neural crest cells contribute to is very large (Figure 
1). In addition to being the precursor of melanocytes, neurons and glia of the peripheral 
nervous system, cranial  neural  crest  cells  contribute to most of the cartilage,  bone and 
connective tissue of the face. Because these multipotent cells have self renewal properties, 
they were considered to be stem cells or stem cell like cells (Labonne et al., 1998). 
Figure 1: Shows the different cell types and tissues or organs derived from neural crest 
cells. 
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Trainor et al., 2003.
Neural crest cells are induced at the border between the neural plate and the non-
neural ectoderm. They undergo epithelial to mesenchymal transition. They delaminate and 
migrate to ventral regions and ultimately differentiate into a variety of tissues.
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Induction of Neural Crest Cells
Neural crest cells arise at the dorso-lateral edge of the closing neural fold along the 
entire length of the vertebrate embryo neuraxis (Reviewed in Trainor, 2003). This occurs 
specifically at the neural plate border, between the dorsal region of neural plate and the 
non-neural ectoderm (surface ectoderm). 
It has been shown that, cells in the dorsal region of the neural tube can give rise to 
both, neural tube and neural crest derivatives. Since proteins such as, bone morphogenetic 
proteins (BMPs) which is a member of the growth factor beta family (Liem et al., 1995), 
fibroblast growth factors (FGFs) (Monosoro et al.,  2003) and the Wnt signal family are 
critical in determining the fate of neural plate cells (neural or epidermal), it is expected that 
these proteins also play a role in the induction and the specification and the differentiation 
of neural crest cells. 
In the stage of open neural plate, BMP proteins are highly expressed in the non-
neural ectoderm. But while the neural tube is closing, levels of expression of BMP goes 
down in the non-neural ectoderm, but continues to be expressed in the dorsal neural tube. 
These findings, led to the hypothesis that BMP secreted by the non-neural ectoderm induce 
the neural plate to induce the formation and migration of neural crest cells. A study was 
performed by Liem et al, (1995), where the group investigated what factors control the 
dorsalization the neural plate. The group examined the hypothesis that,  adjacent tissues 
may  be  inducing  the  differentiation.  They  examined  the  effect  of  both  the  epidermal 
ectoderm and the  paraxial  mesoderm,  since  these  tissues  have  been  implicated  in  the 
differentiation of neural crest cells. Ventral neural plate explants were grown in contact 
with surface ectoderm or paraxial mesoderm derived from stage 10 quail or chick embryo. 
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By  40  hours,  ventral  and  intermediate  explants  grown  in  contact  with  the  epidermal 
ectoderm, started producing neural crest cells. In the same study, the pattern of expression 
of BMP proteins, especially BMP4 and 7, in the neural tube,  indicated its potential  of 
driving the differentiation. This was also supported by the induction of slug, which is a 
marker of neural crest cells, by BMP4. 
The restriction of  neural  cells  generation to the neural  and epidermal  ectoderm 
boundary is controlled by factors that are upstream of BMP4. In the epidermal ectoderm 
Delta1, which is a gene that encodes a ligand that specifically binds to Notch, regulates 
slug  expression  through  the  BMP4 signaling  pathway  (Figure  2)  (Endo et  al.,  2002). 
Therefore, the inhibition of Delta in the non-neural ectoderm will repress the formation of 
Slug.  Which  can  then  be  rescued  by  BMP4  expression.  The  pathway  starts  by  the 
expression of Delta1 from the non-neural ectoderm, which activates notch, that ultimately 
promote expression of BMP4 in the non-neural  ectoderm. It  was also shown that  that 
overexpression of Notch will lead to down regulation of both Slug and BMP4 (Reviewed in 
Trainor et al., 2003). This implies that Notch is needed in modest levels in order to promote 
activation of BMP4 and Slug. Interestingly, although Notch will promote the expression of 
BMP4 in the epidermal ectoderm, it inhibits Slug’s expression in this region. In this way, 
Notch defines the signals for neural crest specification only in the neural folds. With this 
system, Notch can be thought to tightly regulate the region for the induction of neural crest, 
by restricting induction by BMP4 to the neural plate border (Endo et al., 2002).
A study done by Garcia-Castro et al., (2002) showed that BMP4 expression alone is 
not enough to induce neural crest cells formation. In chemically defined DMEM without 
supplementation, BMP signaling alone was not able to induce the formation of neural crest 
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cells  in  avian neuroepithelial  explants.  Also in  this  study,  the group showed that  Wnt 
signaling,  which  is  a  group  of  proteins  that  participate  in  pathways  important  in 
development, was able to induce the formation of neural crest cells. This was indicated by 
the increased expression of slug. In addition when the expression of Wnt was inhibited, 
slug expression decreased and the formation of neural crest cells was abrogated. 
In  another  study that  also  showed the importance  of  Wnt  in  neural  crest  cells 
induction,  by Saint-Jeannet et al., (1997). In this study Wnt was overexpressed in xenopus 
embryo. This resulted in an increase in several neural crest markers. This is also supported 
by the observation that Wnt1/Wnt3a double mutant mice exhibit skeletal abnormalities, and 
extreme reduction in cranial  and spinal sensory neurons, all of which are derived from 
neural crest cells (Ikeya et al., 1997). A very recent study by Patthey et al., (2009), showed 
that, it’s the interaction of both BMP4 and Wnt that is important in determining the fate in 
either being in the neural-epidermal border or in the epidermal region.
In 2003, Monsoro-Burq et al, showed that FGF signaling from the mesoderm is also 
an  important  player  in  neural  crest  induction.  From all  of  these  experiments,  we  can 
conclude that BMP, Wnt and FGF signaling pathways, are important and play a critical role 
in the neural crest cells formation.
11
Figure 2: The hypothesized model for the regulation of BMP signaling, Notch signaling 
and Slug expression.
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Endo et al, 2002.
Delamination of Neural Crest Cells
13
The migration  of  the neural  crest  cells  occur  almost  at  the same time of  their 
induction along the dorso-lateral edge of the neural plate. This begins with their transition 
to the mesenchymal type before they can migrate. 
The transition of neural crest cells from epithelial cells to mesenchymal cells, is 
marked with the change of expression of the cell adhesion proteins. Most important, are the 
cadherin proteins. Cadherins get their name from their dependence on calcium for their 
function, they were first called, calcium dependant adhesion molecules. These protein are 
transmembrane proteins that play an important role in cell adhesion, ensuring cells within 
tissues  are  bound  together.  It  was  found  that  during  delamination,  neural  crest  cells 
downregulate  multiple  adhesion  molecules  such as  N-Cadherin  and Cadherin6B and it 
upregulates Cadherin7 and Cadherin11 (Kimura et al., 1995; Nakagawa et al., 1998). In 
one  study,  the  group  overexpressed  flag-tagged  N-Cadherin  and  Beta-Galactosidase 
(control) by injecting adenovirus shuttle vector with the coding sequences into the lumen of 
the neural  tube in  chick embryos (Nakagawa et  al.,  1998).  After detecting the ectopic 
expression of N-Cadherin, the effect that this expression had on the delamination or the 
migration of the neural crest cells was observed. The cells that were positive for Beta-
galactosidase, had normal delamination and migration (detected by whole mount staining). 
However,  in  embryos  expressing  ectopic  N-Cadherin,  no  infected  cells  were  found 
migrating along the dorso-lateral  region (detected using an anti-FLAG antibody). Cells 
accumulated in the mid-line of the neural tube, some of which had invaded the lumen of 
the neural tube. These results supported the idea that the control of cadherin activity or 
expression is essential for neural crest emigration.
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One of the most important hallmarks of neural crest cells formation in addition to 
Slug,  is a transcription factor called Snail.  When Snail  was overexpressed in epithelial 
cells, the cells adopted a fibroblastoid phenotype and acquired tumorigenic and invasive 
properties  (Cano  et  al.,  2000).  Thus,  snail  acted  as  a  transcriptional  repressor  of  E-
Cadherin. This inhibition is expected to prevent the epithelial-mesenchymal transition and 
subsequently inhibit neural crest cells migration. So there is a cadherin switch that needs to 
be balanced for the neural crest cell to migrate. It was also shown that when Slug antisense 
mRNA oligonucleotide  was used in avian embryos, it resulted in the inhibition of cranial 
neural crest migration. 
BMP  expression  as  was  mentioned  above  is  important  for  neural  crest  cell 
induction. It was found that BMPs also play a role in delamination. Upstream, is the Delta-
Notch  signaling pathway,  that  promotes  BMP4 and at  the same time,  it  inhibits  Slug 
expression.  This  suggest  a  mechanism through which these players  tightly  control  the 
formation and delamination of neural crest cells at the neural-epidermal junction .
Another factor that is thought to be important in the delamination of neural crest 
cells, is the GTP-binding protein RhoB. The importance of this protein was first suggested, 
because of its selective expression in the dorsal neural tube and its transient expression in 
the neural crest. RhoB is also induced by BMPs, and the inhibition of RhoB results in the 
prevention of the delamination of neural crest from the dorsal epithelium (Liu and Jessell, 
1998).
In an attempt to identify the mechanism by which a subset of dorsal neural tube 
cells ultimately give rise to neural crest, Barembaum et al., (2000), screened for molecules 
expressed in the early developing nervous system. One of these molecules was Noelin-1. 
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The  delamination  and  migration  of  neural  crest  cells  from  the  neural  tube  after  the 
conversion of the neuroepithelial precursors from epithelial to mesenchymal, is a transient 
event. The maintenance of neuroepithelial precursors to keep producing neural crest cells is 
what  is  most  important.  This  appears  to  be  regulated  by  the  glycoprotein,  Noelin-1. 
Noelin-1 is initially expressed along the edges lateral edges of the neural plate but is also 
expressed later in migrating neural crest cells. Overexpression of Noelin-1 in the neural 
tube using retroviral infection resulted in increased numbers of neural crest cells over the 
dorsal neural tube in the  Noelin-1 injected embryos (detected by staining for the neural 
crest marker HNK-1). This suggested an over production of cranial neural crest cells. From 
these results, Noelin-1 may be maintaining the period during which the neural epithelium is 
competent to generate neural crest cells.
Migration of Neural Crest Cells
Migrating cranial neural crest cells can be divided into forebrain, midbrain and hindbrain. 
These cells move along precise, species specific and region specific pathways between the 
cranial ectoderm and mesoderm (Reviewed in Walker et al.,  2006). The most profound 
aspect in the migration and patterning of the cephalic neural crest cells migration is the 
apparent segregation of the frontnasal, first pharyngeal arch, second arch, and third arch 
population from one another, the patterns of which are highly conserved in all vertebrate 
species as disparate as amphibians, teleosts, avians, marsupials and mammals (Figure 3). 
Forebrain and rostral midbrain neural crest cells colonize the frontonasal and periocular 
regions. Caudal midbrain derived neural crest cells populate the maxillary component of 
the first pharyngeal arch (Reviewed in Walker et al., 2006). The hindbrain is transiently 
partitioned into seven segments called rhombomeres (Vaage et al., 1969) and neural crest 
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cells  emigrate  form each of the rhombomeres forming discrete segregated streams that 
populate the first, second, third and fourth pharyngeal arches. The segregation of distinct 
cranial neural crest cells populations is critical to prevent fusions of the cranial ganglia and 
skeletal elements and also to prevent mixing of neural crest cells with different genetic 
constitutions (Golding J et al., 2000) and this is controlled by the ectoderm, mesoderm and 
endoderm tissues with which the neural crest cells interact. 
Movement of the neural crest cells, mesodermal muscle precursors and ectoderm 
into the pharyngeal arches is dependent on one another. The neural crest cells that arise 
from  the  caudal  midbrain  and  anterior  hindbrain  are  always  associated  with  muscle 
precursors and ectoderm cells that arise from the same axial level.  All of them occupy the 
first pharyngeal arch with the mesoderm forming the central core or the muscle plates. 
These muscle  plates are surrounded by neural  crest  cells  which are surrounded by the 
ectoderm.  This  arrangement  creates  boundaries  which  will  be  conserved through  later 
stages of development when the muscles and their connective tissues move to other parts of 
the head.  This orchestration is  also seen in the cranial  motor nerves and precursors of 
epipharyngeal placode.
All these data suggest that early registration between the different tissues in the 
head during early embryogenesis is critical for the establishment of the foundations of the 
vertebrate craniofacial development. 
Figure 3: Shows the migration of neural crest cells in rat embryo from the neural tube in 
segregated distinct streams into the branchial arches. Neural crest derivatives are distinct 
for erach branchial arch.
17
From Gilbert., 1994. page: 294.
Pathways Specifications of Neural Crest Migration
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Cranial neural crest cells derived from the hindbrain migrate ventro-laterally from 
the  neural  tube  in  three  distinct  distinct  subectodermal  streams  adjacent  to  the  even 
numbered rhombomeres, rhombomeres 2, 4 and 6. These three travelling streams of neural 
crest  cells  accumulate  or  populate  the  first,  second  and  third  branchial  arches  and 
ultimately give rise to a wide variety of cell lineages which are specific for each branchial 
arch. 
The  underlying cause  for  the  neural  crest  exclusion  zones  adjacent  to  the odd 
numbered rhombomeres, rhombomeres 3 and 5, remained puzzling for a long time. In a 
study done by Graham et al 1993, the group found an increased level of apoptosis near the 
rhombomeres 3 and 5 when they stained with acridine orange (in avian embryo). These 
results were further confirmed with electron microscopy. 
In an attempt to rescue r3 and r5 crest from cell death, the group used tissue culture. 
Individual stage 10 rhombomeres, completely purified from contaminating mesenchyme, 
were prepared and were plated onto fibronectin/poly-L-lysine substrata to allow neural 
crest cells to crawl out. Surprisingly, both even and odd-numbered rhombomeres produced 
cells that migrated away from the neural tube and that these cells had a typical neural crest 
cell morphology. The group then stained the explants for HNK-1 which is the marker of 
neural crest cells to detect if there were any differences between the odd and the even. So 
when single rhombomere was dissected from the animal and grown in vitro, they produced 
healthy neural crest cells. 
It seems that signals from the even numbered rhombomeres which are mediated by 
BMP4 induced Msx2 expression in rhombomeres 3 and 5, causes the apoptotic elimination 
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of premigratory neural crest cells in rhombomeres 3 and 5. As a result neural crest cells 
segregate into discrete streams. 
Another study done by Ellies et al, (2002), added another player to the game. In this 
study the group was able to inhibit apoptosis. This was done by the over-expression of Wnt 
antagonist, sFRP2, which inhibited BMP signaling pathway. These data suggest that, the 
apoptotic  elimination  of  neural  crest  cells  precursors  is  modulated  by  a  Wnt  –  BMP 
signaling  pathway.  Furthermore,  that  this  machinery  is  important  in  the  evolutionary 
elimination  of  unnecessary  muscle  attachment  sites  (Ellies  et  al.,  2002;  Reviewed  in 
Trainor, 2003). 
Because early examinations of neural crest cell death were performed in serum rich 
media, the hypothesis that proposes BMP4-Msx2 mediated cell death in odd rhombomeres 
remained controversial. When studies have been performed to repeat the findings of BMP4 
dependence  in  chemically  defined  media  instead  of  the  serum,  the  results  were  not 
replicated. The studies failed to demonstrate any significant link between BMP signaling 
pathways and neural crest cell death in odd numbered rhombomeres (Farlie et al., 1999). 
Further  studies  showed  the  importance  of  the  “adjacent  microenvironment”  in 
neural  crest  cells  apoptosis.  Blocking  neural  crest  cells  death  in  odd  numbered 
rhombomeres does not block or disrupt the segregation of neural crest cells. This finding 
signifies the importance of the microenvironment adjacent to the neural tube in regulating 
the path of neural crest cell migration (Golding et al., 2000). The influence or the effect of 
the  microenvironment  is  clearly  evident  from time-lapse  imaging  of  neural  crest  cell 
migration and lineage tracing in avian embryos. And this demonstrated that rhombomeres 3 
and 5 do in fact produce neural crest cells. But the neural crest cells derived from these odd 
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numbered rhombomeres migrate differently than the even numbered ones. Neural crest 
cells  originating from the odd numbered rhombomeres 3 and 5 migrate  anteriorly  and 
posteriorly instead of laterally and they join the neural crest cell streams that originated 
from even numbered rhombomeres. These data showed that the presence of neural crest 
cell  free zones and the segregation of the cells into discrete streams is not an intrinsic 
property of the hindbrain and the odd rhombomeres in specific (Reviewed in Trainor et al., 
2003). These data also emphasize that the regulation of the pathways of neural crest cell 
migration is influenced by the microenvironment adjacent to the neural tube. 
Another  notion  that  explains  the  segregation  of  the  neural  crest  cells  into  the 
distinct  streams  and  the  reciprocal  transplantation  of  the  cells  between  odd  and  even 
numbered  rhombomeres  is  that,  the  intrinsic  or  inter-rhombomeric  signaling  is  less 
important than the combinatorial interactions between the hindbrain and adjacent paraxial 
tissue in the process of restricting the generationa and migration of neural crest cells. This 
notion is supported by a study, in which ErbB2 null mutant mice were examined (Golding 
et al., 2000). The group found that neural crest cells derived from rhombomere number 4, 
acquire  the ability  to migrate  through the dorsal  mesenchyme adjacent to rhombomere 
number 3.  The expected cause of  the aberrant  migration is  a group of changes in  the 
paraxial mesenchyme environment and is not autonomous to the neural crest cells. ErbB4 
is normally expressed in the rhombomeres 3 and 5, so the observed phenotype reflects 
defects  in  the  signaling  between  the  hindbrain  and  the  adjacent  microenvironment 
(Reviewed in Trainor et al., 2003). 
Despite of the mechanism that underlies the segregation of neural crest cells into 
the distinct streams, this process has an importance in the separation of Hox-expressing 
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neural crest cells and the non-Hox expressing neural crest cells. Hox are a group of genes 
that specify the anterior-posterior axis in organisms during early embryonic development. 
It also specifies segment identity. A study by Pasqualetti et al., (2000), in which the group 
made full-length constructs derived from XHoxa2, mouse Hoxa2 and zebrafish Hoxa2. 
They then injected full RNA’s into the blastomeres of two cell stage Xenopus embryos. 
Specific  alterations  of  the neural  crest-derived  skeleton  of  the pharyngeal  arches  were 
observed. The group couldn’t find any differences between the different RNA’s (Xenopus, 
mouse and zebrafish) indicating the conservation of the protein. The group finally found 
that Hoxa2 induction at postmigratory stages results in mirror image transformation of a 
subset  of  jaw elements,  normally  lacking Hox expression,  towards  hyoid morphology, 
which is the reverse phenotype to that observed in the Hoxa2 knockout.
It was also shown that over-expression of Hoxa2 in the first branchial arch neural 
crest cells, transforms and converts the identity of the first arch into that of a second arch 
(Grammatopoulos et al., 2000). This will ultimately suppress jaw formation (Pasqualetti et 
al., 2000). The reverse of this observation is seen in Hoxa2 null mice, in which the second 
arch identity is transformed into a first arch identity, and that results in the duplication of 
the first arch skeletal structures. 
Cranial ganglia fusions were observed in a number of mouse mutations that resulted 
in mixing of the neural crest streams. From this, we may conclude that the segregation of 
the neural crest cells in their distinct streams is important for proper jaw formation and 
normal head development. 
Craniofacial Development & Patterning of Neural Crest Cells
22
The  experiment  that  showed  when  neural  crest  cells  from the  first  arch  were 
transplanted posteriorly to the second or third arch lead to the formation of duplicate first 
arch skeletal elements, put the basis for the classical view of craniofacial devekopment and 
neural crest patterning. And this states that regional diversity in the vertebrate head was a 
consequence of patterning information provided by the neural crest (Hunt et al.,  1991). 
These duplicated crest-derived structures were not only un-usual for their new location, but 
connections, attachments and muscle cell type associated with these structures were also 
typical of a first arch pattern (Reviewed in Trainor et al., 2003). 
These  data  suggest  many  ideas  that  ultimately  lead  to  the  “neural  crest  pre-
programming” model. The hypothesis is, that the neural crest cell fate must be programmed 
prior  to  the  emigration  of  the  cells.  Another  hypothesis  is,  that  the  myogenic  cell 
populations  or  other  cell  types,  receives  signals  from the migrating neural  crest  cells-
connective derivatives. For instance, most of the cranial neural crest cells arise from the 
hindbrain, and it was found that the same restricted domains of the Hox gene expression 
found in the hindbrain, also continues in the migrating cranial neural crest cells. And also 
in their derivatives,  thus reflecting the origins of the neural  crest  cells  constituting the 
tissues  (Hunt  et  al.,  1991).  All  these  observations  led  to  the  neural  crest  cells  pre-
programming model, which said that positional information’s encoded by the Hox genes 
were carried from the hindbrain to peripheral tissues and branchial arches by the neural 
crest (Hunt et al., 1991). 
New information emerged when more studies were done examining the plasticity of 
neural crest cells and trying to understand the real mechanisms contributing to craniofacial 
patterning. Especially with the studies that included neural crest cells transpositions within 
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the hindbrains of the mouse. In study performed by Trainor & Krumlauf et al., 2000, the 
group did a series of heterotopic transpositions of neural crest cells in which they grafted 
rhombomeres 3, 4 or 5 cells in rhombomere 2. The group focused on the donor cells that 
did  not  maintain  their  reporter  gene  expression  and  were  dispersed  in  their  new 
environment. They found that, despite previous evidence for autonomy of gene expression 
in rhombomeric tissue,  the results showed that individual  rhombomeric cells  can show 
plasticity with respect to Hox expression and they are able to change their fate. These data 
indicate  that  cells  in  ectopic  location,  lack  the  signal  from their  normal  neighbors  to 
maintain their identity and that the community that surrounds the cell has a very significant 
effect too.
Another study that supported the idea of the importance of cell-community was 
performed  using  zebrafish  embryos.  The  transplanted  cells  were  followed  for  longer 
periods. Examining their gene expression, it was found that the cells activated new gene 
expression programs and they differentiated and contributed to the pharyngeal cartilages 
appropriate to their new axial location (Schilling et al., 2001). 
The  results  that  were  obtained from the studies  that  involved transpositions  of 
neural crest cells in both mice and zebrafish hindbrains, contradicted the idea that said that 
the axial  character  of neural  crest  cells  is  fixed or it  is  passively transferred from the 
hindbrain to the pharyngeal arch’s and the periphery of the head. These studies proposed a 
new  model,  which  Trainor  et  al,  called  in  his  review  “neural  crest  plasticity  and 
independent  gene  regulation  model”  as  a  mechanism  for  describing  neural  crest  and 
craniofacial development. But why this model was not seen in avian embryos, in which the 
“pre-programmed neural cresl cells” model was strongly suggested, is because of the size 
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and tissue that were used in the study and also timing effects. When whole hindbrains oe 
rhombomeres are translplanted, signals between the rhombomeres or from neighbor cells 
may cause re-inforcement of the cells identity of the transplanted cells. But in the studies 
done on mice and zebrafish, only small rhombomeric cell populations or single cells were 
transplanted. So graft derived migrating neural crest cells will be more likely to respond 
better to the new environment in which they were transplanted. This makes the mice and 
zebrafish studies more powerful and significant that the ones performed on avian embryos. 
CHAPTER 2: Pathogenesis of Treacher Collins Syndrome
Identification of the TCOF1 gene
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Using  highly  informative  short  tandem  repeat  polymorphisms  and   positional 
cloning, the Treacher Collins Syndrome Collaborative group (1996) identified a novel gene 
of  unknown function,  which  they  designated  TCOF1,  within  the  TCS  critical  region, 
between the RPS14 gene (proximal) and ANX6 gene (distal) on chromosome 5 (5q32 – 
q33.1) (Dixon et al, 1993 and TCS collaborative group, 1996). The genomic sequence of 
the gene was isolated and it was shown that it consists of 26 exons and encodes a low 
complexity, serine/alanine - rich protein of approximately 144 kD called Treacle (Dixon et 
al  1997). The deduced 1,411-amino acid protein has 3 conserved domains,  including a 
LisH (LIS1-homology) motif at the N- terminus (Emes and Ponting, 2001), followed by 
alternate repeats of acidic and basic residues and multiple nuclear localizing signals and a 
single nucleolar localizing signal at the C-terminus (figure 5). Indirect immunofluorescence 
shows that treacle is localized to the nucleolus in Hela cells and fibroblasts from healthy 
unaffected individuals (Isaac et al., 2000). The repetitive protein motifs are shared with 
nucleolar trafficking proteins in other species and are predicted to be highly phosphorylated 
by casein kinase II (Wise et al., 1997). 
Databases sequence comparisons shows weak but significant homology between 
treacle and Nopp140 which is a rat nucleolar phophoprotein. Like treacle, Nopp140, is a 
low complexity  protein  which  contains  10 repeat  units  of  alternating acidic  and basic 
regions, with each repeat containing numerous casein kinase phospjorylation sites. 
Northern blot analyses show that TCOF1 is expressed in nearly all adult and fetal 
tissues  in  low levels.  A 5.8  kb  transcript  was  detected  in  adult  heart,  placenta,  adult 
pancreas, fetal and adult brain, lung, liver and kidney. In addition, an additional transcript 
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of  6.3  kb  was  also  detected  in  adult  skeletal  muscle  (Treacher  Collins  Syndrome 
Collaborative Group, 1996).
Mutations in TCOF1 gene
In 2004,  Teber and collaborators  performed a study in  which they screened 46 
patients with a clear clinical diagnosis of TCS. The patients were referred to the group 
when they asked for TCS patients and in  addition,  the group re-examined the patients 
clinically. These patients showed the typical clinical findings of TCS including downward 
slanting palpebral fissures, lower eyelid coloboma, hypoplasia of the zygomatic complex 
and mandible, and microtia. It was found that, 78% of the patients did carry heterozygous 
mutations  in  TCOF1,  including  frameshift,  splice  donor  or  acceptor  mutations  and 
nonsense mutations. The majority of these mutations were predicted to truncate treacle, and 
this implies a potential importance of the C-terminal of the protein for its function.  There 
was  no  observed correlation  between  phenotype  variability  and  the  type  of  mutations 
identified. It is also worth noting that 60% of TCS cases are due to  de novo mutations 
(Splendore et al., 2002). The mutations identified in unique families are different. But there 
is  an  occurring  5 base pair  deletion  in  the  TCOF1 gene  (TCOF1 mutations  database, 
www.genome.ib.usp.br/tcof1_database). 
Ribosome Biogenesis
Ribosome biogenesis  is  the process  of  the formation of  the constituents  of  the 
ribosome subunits, their assembly, and their transport to the sites of protein synthesis.  In 
eukaryotes  ribosome  biogenesis  occurs  in  the  nucleolus,  which  is  a  specialized 
compartment within the nucleus. The process begins with the synthesis of a large pre-
rRNA transcript  (Figure 5) by RNA polymerase I.  This transcript  then goes through a 
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complex series of processing, modification and folding steps. This will ultimately lead to 
the  formation  of  the  mature  18S,  5.8S  and  25/28S  ribosomal  RNAs  which  will  be 
assembled into functional ribosomal subunits. 
Eukaryotes have 80S ribosomes, each consisting of a  small 40S and a large 60S 
subunit. The large subunit is composed of a 5S RNA (120 nucleotides), a 28S RNA (4700 
nucleotides), a 5.8S subunit (160 nucleotides) and ~49 proteins. The 40S subunit has a 
1900 nucleotide (18S) RNA and ~33 proteins. These mature RNA components are released 
from the pre-rRNA following a very complex maturation pathway. Pre-rRNA undergo a 
number  of  modifications  and  are  bound  by  ribosomal  proteins  before  the  assembled 
pre-40S and pre-60S are exported separately to the cytoplasm (Reviewed in Venema and 
Tollervey, et al 1999). 
The complex process of maturation of ribosomal rRNA and its assembly into the 
final eukaryotic ribosomal subunits involves at least 170 accessory proteins. These proteins 
are exonucleases (an enzyme that cleaves nucleotides one at  a time from the end of a 
nucleotides  chain),  endonucleases  (an  enzyme  that  cut  phosphodiester  bonds  between 
nucleotides), RNA helicases (an enzyme that unwinds annealed nucleic acid strands) and 
chaperones  or  assembly  factors  and almost  as  many small  nucleolar  ribonucleoprotein 
particles (snoRNP’s) (Fromont-Racine et al., 2003). 
The two major modifications of pre-rRNA, are methylation and pseudouridylation. 
Both of these modifications depend largely on the snoRNA’s. There are two families of the 
snoRNAs, box C/D antisense snoRNAs and ACA snoRNAs (Reviewed in Cavaille et al., 
1996). SnoRNAs of the first family contain two short sequence motifs, box C and box D, 
and 10-21 nt sequences complementary to rRNA. A specific box C/D antisense snoRNA is 
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associated with each methylated nucleotide in ribosomal RNA, which precisely targets the 
position  to  be  methylated  in  pre-rRNA through  transient  formation  of  a  long  duplex 
structure at the modification site. The other family of snoRNA, is the ACA family. This 
family is defined by the presence of a 3’ ACA sequence, which guides pseudouridylation at 
a particular ribosomal RNA site through specific base pairing with ribosomal RNA. 
In order to carry out the modifications, each snoRNA associates with at least four 
protein molecules in the RNA/protein complex snoRNP. The proteins associated with each 
RNA depend on the type of snoRNA molecule (C/D box member or ACA snoRNA). As 
mentioned  above,  the  snoRNA  molecules  contain  an  antisense  element  (about  10-20 
nucleotides) which are base complementary to the sequence surrounding the nucleotide 
targeted for modification in the pre-rRNA. This enables the snoRNP to recognize and bind 
to the target RNA. Once the snoRNP has bound to the target site the associated proteins are 
in the correct physical location to catalyze the chemical modification of the target base. It is 
also worth noting that, the modifications of pre-rRNAs are important for the final three-
dimensional structure of the mature ribosome. 
Figure 4:  A schematic of pre-RNA, indicating the mature 18S (red),  5.8S (green) and 
25/28S (blue)  rRNAs which  must  be  removed from the  precursor.  An ordered  set  of 
cleavages  remove  the  5′  and  3′  external  transcribed  spacers  (ETS)  and  the  internal 
transcribed spacers, ITS1 and ITS2.
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Peculis et al., 2005.
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Treacle Function
Treacle is classified as a nucleolar phosphoprotein due to the conserved acidic and 
basic repeats and its localization to the nucleolus (Winokur and Shiang, 1998). Treacle is 
also  known  to  physically  interact  with  upstream  binding  factor  (UBF),  which  is  a 
transcription factor for RNA polymerase I, and hence may play a role in the transcription of 
ribosomal  DNA  (Dixon  et  al,  2004).  Examination  of  the  cDNA-derived  amino  acid 
sequence of the human treacle using the website http://motif.genome.ad.jp show 13 High 
Mobility Group (HMG) DNA binding domains, which preferentially bind to the minor 
groove of AT-rich regions in double-stranded DNA, distributed throughout the molecule 
(Gonzales  et  al.,  2005).  Chromatin  immunoprecipitation  (ChIP)  assay performed using 
HeLa cells, showed that treacle binds to the 5’ external transcribed spacer 1 (ETS1) and to 
promoter region of rDNA (Gonzales et al.,  2005).  The proposed model for the role of 
treacle in the transcription of rDNA is that  treacle binds to the ETS1 and to promoter 
region of rDNA and this  physically  blocks RNA polymerase I  from transcribing.  This 
happens in early mitosis when RNA polymerase I is shut down. In late telophase, treacle 
interacts  with  UBF,  and  this  promotes  its  dissociation  from  ETS1  and  lead  to  the 
transcription of rDNA (Valdez et al., 2004). Data obtained from the ChIP assays support 
the proposed model. Treacle was shown to to bind to the promoter region of rDNA genes 
and the ETS1 and was also shown to physically interact with UBF which is a part of the 
transcription  initiation  complex.  Additional  experiments  in  which  ChIP  assays  can  be 
performed, once when cells are blocked in early mitosis and again when cells are blocked 
in early G1 phase, would be suitable to confirm the proposed model.
A study performed by Valdez  et  al.,  (2004),  showed the importance of  treacle 
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binding to the promoter region of the ribosomal genes. Short interference RNA (siRNA) 
that  targets  the  5’  end  of  exon  3  of  TCOF1  mRNA was  used  to  downregulate  gene 
expression. The level of rDNA transcription was examined using ³²P- labeled antisense 
riboprobe that binds to the 5’ end of pre-rRNA. It was found that Hela cells that were 
treated with the siRNA that targeted TCOF1 gene, showed 47% decreased production of 
pre-rRNA compared to the control (unrelated siRNA). To test this finding in an  in vivo 
model, the level of transcription of rDNA in heterozygote Tcof1+/- mouse embryos was 
examined. Embryos from DBA x C57BL/6 cross were genotyped and the level of Tcof1 
was determined by RT-PCR to identify heterozygotes. RNA samples of Tcof1+/- embryos 
were examined using ³²P- labeled antisense riboprobes that binds to the 5’ end of pre-rRNA 
and it  was  found that,  in  the Tcof1+/- mice,  the production  of  pre-rRNA was reduced 
compared to wild type mouse embryos. Reduced pre-rRNA production is observed in both 
in  vivo and  in  vitro  models  when  Tcof1  is  decreased.  These  findings  suggest  that 
insufficient treacle levels will lead to the absence of its binding to the promoter region of 
ribosomal genes.  Therefore,  there will  be less of UBF in the transcription preinitiation 
complex, and ultimately reduced transcription. 
Treacle was also found to interact with selectivity factor I (SL1), which binds to the 
promoter region of rDNA genes to position RNA polymerase I properly and acts as a 
channel for regulatory signals in the nucleolus (Valdez et al, 2004). This might be due to co 
localization of both SL1 and TCOF1 on promoter regions of rDNA. Treacle was also found 
to  interact  with  Nop56p,  a  component  of  the  ribonucleoprotein  (RNP)  complex  that 
mediates the 2’-O-methylation of pre-ribosomal RNA during early stages of pre-rRNA 
processing (Hayano et al, 2003). 
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These data imply that treacle is also a part of an RNP complex in the nucleolus and may be 
specifically involved in governing the ribosome biogenesis process which is important for 
normal cell growth and proliferation. This is also supported by the fact that treacle shares a 
significant homology with Nopp140, which also associates with RNA polymerase I and 
leads to decreased rRNA production if inhibited (Hung-Kai et al, 1999). Mice that were 
haploinsufficient for Tcof1, exhibited diminished mature ribosome production as measured 
by the levels of 28S rRNA. This deficiency was observed in the neural ectoderm as well as 
in  the neural  crest  but  not  in  tissues such as  the endoderm implying that  treacle  may 
function as a tissue-specific regulator of ribosome biogenesis (Dixon et al, 2006). From 
these findings, Treacle is thought to link RNA polymerase I-catalyzed transcription and 
post- translational modification of pre-rRNA. 
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Figure  5: Treacle  with  three  conserved  domains:  LisH  (Lissencephal-Homology),  10 
repeats of acidic and basic residues and multiple nuclear localizing signals (NLS) and a 
nucleolar localizing signal (NoLS).
LisH Acidic and basic residues Multiple NLS and NoLS CN
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Underlying Cause of Phenotype of TCS
Mouse  model  of  TCS  has  been  extensively  used  in  studies  to  understand  the 
developmental  abnormality associated with the disease.  The tissues that  are affected in 
Tcof1 mutant mouse embryos are derived entirely or in part from neural crest cells. The 
underlying cause of these observed craniofacial anomalies in the Tcof1 knockout mouse 
embryos  is  an  increase  in  apoptosis  in  the  neuroepithelium (Dixon  et  al.,  2005).  The 
neuroepithelium is present prior to the onset of neural crest cells induction, which occurs 
around embryonic day 8 (E8) and continues until  E9 and E10. This overlaps  with the 
period of neural crest cells induction and migration during mouse embryogenesis (Poswillo 
et al., 1975). 
At the same time, studies performed on Tcof1 +/- mice showed that neural crest 
cells migration was not hindered as a separate process. This leads to the conclusion or the 
hypothesis that the facial abnormalities characteristic of Treacher Collins Syndrome appear 
to arise due to problems that originate within the neural plate. Excessive neuroepithelial 
apoptosis is likely to result in a reduced number of neural crest cells that migrate into the 
frontnasal region and pharyngeal arches. 
Consequently  it  has  been  hypothesized  that  deficient  ribosome  biogenesis  is 
incapable  of  meeting  the  cellular  and  metabolic  needs  of  the  highly  proliferative  cell 
populations  in  the  neural  ectoderm  and  neural  crest  during  embryogenesis  and  more 
specifically it is directly responsible for the high levels of cell death observed in these cell 
populations at the time of formation. Insufficient ribosome biogenesis leading to increased 
neuroepithelial apoptosis and deficient formation of migrating cranial neural crest cells is 
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causing the hypopasia of cranioskeletal elements in TCS, because the majority of bones, 
cartilages and connective tissues in the head and face are derived from neural crest cells.
Identification of The Apoptosis Pathway of TCS
Infants  with  TCS  that  have  severe  hypoplasia  of  the  mandible  and  zygomatic 
complex  typically  have  cleft  palate  along  with  narrowed  airways  and  consequently 
experience major breathing and feeding problems (Reviewed in Trainor et al,  2008). In 
most cases new born infants require immediate tracheostomy. Repairing the phenotype of 
TCS  require  the  collaborative  work  of  craniofacial  surgeons,  orthodontists, 
ophthalmologists,  otolaryngologists  and  speech  pathologists.  Still  the  results  remain 
variable and not fully corrective (reviewed in Sakai et al, 2008). 
A  recent  study  has  shown  that  the  protein  p53  is  found  to  be  activated  and 
stabilized in the neuroepithelium of Tcof1 heterozygote mutant mouse embryo, along with 
other p53 responsive pro-apoptotic proteins. A genome wide expression analyses of E8.5 
Tcof1 +/- mice embryos was compared to wild type mice of the same age by microarray 
analysis (Jones et al.,  2008). As was mentioned above, the increase in neuroepithelium 
apoptosis that occurs in Tcof1 heterozygote mice, happens at around E8. For that reason, 
the group decided to look at gene expression at this time point. It is worth mentioning that 
the Tcof1 heterozygote knockout mice used in the study, had a reduction of Tcof1 of about 
40%. 
A number of genes were found to be upregulated in the Tcof1 +/- mice as compared 
to the wild type. One of the genes was the Ccng1, which encodes cyclin G1, which is a p53 
responsive gene that inhibits growth and arrests cells in the G1 phase of the cell cycle. 
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Another gene that was also found to be upregulated was Noxa, which is a member of the 
Bcl2 family and is known to be important in mitochondrial  fragmentation and caspase 
activation.  Both  of  these  genes  and  many  more  that  were  found  to  be  differentially 
expressed in the Tcof1 +/- mutant mouse embryo epithelium, are known recognized targets 
and  mediators  of  p53-dependent  transcription.  But,  p53  itself  was  not  found  to  be 
upregulated. 
Therefore  the  level  of  the  protein  that  the  gene  p53  encodes  was  examined. 
Normally, p53 protein is readily degraded and has a short half life of about 20-30 minutes 
and is thus usually maintained in very small and often undetectable levels. As expected, the 
ummunoblot analysis showed an increased level (2.28 fold) of p53 protein in the E10.5 
Tcof1 +/- embryos than in their wild type littermates. 
This finding indicates that there is a post-translational control of the level of p53 
protein. But in order to prove the link between the increased levels of p53 and the apoptosis 
seen in the neuroepithelium, immunostaning of embryos of the age of 8.5-9.5 with antibody 
specific to p53 was performed. While the expression was barely detectable in the wild type 
embryos,  in  the  Tcof1  +/-  embryos,  increased  level  of  staining  was  confined  to  the 
neuroepithilium. Further quantification of the intensity of the signal showed that there is an 
increase of  about  1.8  fold.  Even when counterstained with DAPI,  the p53 signal  was 
showed  to  be  restricted  to  the  nuclei  of  the  neuroepithelium.  This  also  supports  the 
hypothesis that, increased apoptosis in the epithelium results in reduced migration of neural 
crest cells. 
After confirming the stabilization of p53 in the neuroepithelium, the potential of 
being able to prevent the onset of TCS with the inhibition of p53 was investigated. Pifithrin 
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was used,  which is  a known inhibitor of p53 that  inhibits  its  binding Bcl-xl and Bcl2 
proteins. Pregnant mice were given pifithrin-alpha once daily starting from E6 to E8.5. The 
timing here is  very important  because at  this  time point,  the neuroepithelial  apoptosis 
occurs in the Tcof1 +/- embryos. Control pregnant females were given PBS. Embryos were 
collected at age E8.5 which coincides with the formation and migration of neural crest 
cells,  and  these  embryos  were  assayed  for  apoptosis  by  TUNEL  (Terminal 
Deoxynucleotidyl Transferase dUTP Nick End Labelling), which is a technique used to 
detect DNA fragmentation as a result of apoptosis. In 67% of Tcof1 +/- embryos that were 
treated  with  pifithrin-alpha,  neuroepithelium  apoptosis  was  substantially  reduced,  as 
compared to the Tcof1 +/- embryos that were not treated or the ones that were given PBS. 
Then  an  attempt  to  rescue  the  phenotype  by  inhibiting  p53  genetically  was 
performed. The progeny of the intercrosses of Tcof1 +/- and p53 +/- mice were assayed for 
apoptosis at E8.5 using antibody specific to caspase-3. It was found that the loss of one 
copy of the p53 gene, resulted in reduced amount of neuroepithelial apoptosis in the Tcof1 
+/- embryos as compared to the Tcof1 +/- embryos with wild type p53. Furthermore, the 
loss of the two copies of p53, abrogated caspase-3 activity as compared to only copy being 
missing. The mice that resulted from these matings looked normal and the phenotype was 
successfully rescued. But after 6 months, a number of p53 -/- mice developed tumors and 
had to be sacrificed. This is the major caveat with this rescue. Previously it has been well 
established that p53 is a tumor suppressor gene that functions in cell cycle arrest regulation, 
detection of DNA damage, centromere amplification and apoptosis (Haupt et al, 2003). So 
it is expected that losing a copy or both of this gene may have a significant effect on the 
organism.
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The p53 protein is known to get activated and stabilized through the inhibition of a 
protein called Mdm2 (or HDM2 in humans). HDM2 is found to be amplified in a number 
of human sarcomas (Oliner et al., 1992). The inhibition of p53 by HDM2 is achieved by 
either the direct binding of HDM2 to p53 or by the E3 ligase activity of HDM2 that can 
target  p53 for ubiquitination (Fang et  al.,  2000).  The ubiquitination of p53 by HDM2 
contributes to the proteasomal degradation of p53 and also to the export of p53 from the 
nucleus to the cytoplasm (Haupt et al., 1997). p53 is a transcription factor that induces 
expression of many genes that mediate the apoptotic and cell cycle arrest response to p53 
induction  (Vousden and Lu,  2002).  Importantly,  p53 can also activate  transcription  of 
HDM2, establishing a regulatory loop in which p53 induces expression of its own negative 
regulator. Stress-induced activation of p53 depends in part on the inactivation of HDM2 
and the inhibition of HDM2-mediated ubiquitination of the p53 protein. The inhibition of 
HDM2 can be achieved through several mechanisms, with different stress signals utilizing 
different pathways to allow stabilization of p53. 
Defective ribosome biogenesis is known to cause what is called a nucleolar stress. 
Nucleolar stress was found to activate a p53 dependent check point and subsequent cell 
cycle  arrest  and  apoptosis  (Pestov  et  al,  2001).  It  was  also  reported  that,  when  the 
biogenesis of ribosomes is impaired, this promotes the release or the diffusion of a number 
of 60S ribosomal proteins into the nucleoplasm. Specifically, a ribosomal protein called 
L11 (Lohrum et al., 2003). Coexpression of L11 with HDM2 and p53 in an in vitro system, 
prevented degradation of p53 in a manner similar to that seen following ARF expression, 
which is  a protein known to bind HDM2’s ubiquitin  ligase active site (Lohurm et  al., 
2003). Furthermore, in U2OS cells, which express wild type p53 and HDM2, but no ARF, 
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elevation of endogenous p53 and HDM2 levels was seen following L11 expression. In the 
same study, HDM2 was found to localize with L11. These findings were replicated after 
the use of actinomycin-D, which selectively inhibit the activity of RNA polymerase I (the 
polymerase responsible for rDNA transcription). In addition, flow cytometric analysis of 
L11 transfected cells showed that expression of L11 and stabilization of p53 led to a G1 
arrest, which was also seen in neuroblastoma cell lines, in which the TCOF1 expression 
was knocked down (Lin et al., 2004). 
The hypothesis is, when Tcof1 gene is mutated and there is less functioning Treacle 
being  produced  leads  to  reduced  levels  of  rDNA transcription,  and  also  to  abnormal 
processing of pre-rRNA. The decrease in ribosome biogenesis, results in the diffusion of a 
number of ribosomal proteins like L11 or L23 (Dai M.S et al., 2004) into the nucleoplasm. 
L11 or L23, inhibit HDM2 by binding to its ubiquitin ligase active site and thus, preventing 
its proteosome mediated degredation of p53. Therefore, the protein p53 gets stabilized and 
activated. A number of p53 targets are activated which leads to cellular arrest in the G1 
phase and ultimately apoptosis. These are the predicted event that leads to the increase in 
apoptosis that was reported to be seen in the neuroepithelium of Tcof1 +/- mouse embryos. 
The best attempt to prevent the onset of TCS was the inhibition of p53 in Tcof1 +/- 
mouse embryos (Dixon et al., 2008) but this resulted in tumor formation which, limits the 
potential  of  using  this  method  for  treating  TCS  in  humans.  Thus,  the  importance  of 
identifying the apoptosis pathway in TCS is evident. Finding a downstream effector of p53-
dependent apoptosis that  was not linked to cancer or tumor progression,  as a potential 
minimal risk candidate for the therapeutic prevention of TCS can be promising. 
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A genome wide analysis was performed in which the genes that were differentially 
expressed with TCOF1 being knockdown or overexpressed were investigated in mouse 
neuroblastoma cell  line  (Mogass  et  al.,  2004).  A number  of  genes  were  found to  be 
coordinately regulated with Tcof1; one of the most significant ones was the T-box2 (Tbx2) 
which had a log2 fold change of 1.56. Tbx2 is a known transcriptional repressor and it 
specifically regulates p19 in mouse embryo fibroblasts (Jacobs et al., 2000). It is known 
that the activation of p19 promotes the stabilization of p53 by inhibiting the E3 ligase 
activity of Mdm2. Interestingly, p19 expression was found to be negatively correlated with 
the expression of Tcof1 and Tbx2. But in the Tcof1 knockdown cell line, in which Tbx2 
expression is decreased, p19 was not found to be activated. 
Two other genes were found to be negatively correlated with Tcof1 expression are, 
Bnip3 and Binp3l. These proteins are known pro-apoptotic proteins (Imazu et al., 1999; 
Chen  et  al.,  1997).  Thus,  the  reduction  in  Tcof1  may  reduce  the  ability  of  a  cell  to 
synthesize proteins due to reduced mature ribosome production, and this could activate an 
apoptotic response through Bnip3 or Bnip3l. As was mentioned before, phenotype seen in 
TCS is caused by increased p53-mediated apoptosis in the neuroepithelium, interestingly, 
Bnip3l is a direct transcriptional target of p53 (Fei et al.,  2004), which makes Bnip3l a 
strong candidate for being a downstream gene in the p53 apoptotsis pathway. 
Another gene that is strongly regulated by the Tbx2, is  Cyclin-dependent kinase 
inhibitor 1A (p21),  also known as  CDKN1A. Tbx2 acts as a transcriptional repressor of 
p21 (S Prince et al., 2004). P21 is also one the main transcriptional targets of p53, which 
was shown to be stabilized in the Tcof1 heterozygote mouse embryos (Dixon et al., 2008). 
P21 protein mediates the p53-dependent cell cycle G1 phase arrest in response to a variety 
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of stress stimuli. Hence, it is possible that, like in DNA damage response, p21 causes G1 
arrest when Tcof1 is decreased and there is deficient ribosome production. And as was 
mentioned above,  p53 is  affected by the nucleolar  stress caused by deficient ribosome 
biogenesis, and this is by the inhibition of Hdm2 by L11binding to  it’s ubiquitin ligase 
active site (Lohurm et al., 2003). In an experiment that aimed to investigate the role of p21 
in regulating the apoptosis/ autophagy switch, mouse embryonic fibroblasts that were p21 
+/+ were compared to p21 -/- MEF’s, when both were treated with ceramide to induce cell 
death and it was found that p21 always turned off the autophagy pathway and promoted 
apoptosis (Fujiwara el at., 2008). In the same experiment, when Z-VAD-FMK was used, 
which is a caspase inhibitor with broad specifity, it inhibited p21 apoptosis in MEF’s.  
In the literature, p21 is reported to promotes apoptosis in response to a variety of 
stimuli  and  in  different  systems.  Overexpression  of  p21  in  thymocytes  led  to 
hypersensitivity to p53-dependent cell death in response to ionizing radiation and UV but 
not to dexamethasone in transgenic animals (Fotedar et al., 1999). Overexpression of p21 
in C3 SV40 T-antigen mammary tumor cells deficient for p53 activity increased apoptosis 
(Shibata et al.,  2001). Overexpression of p21 has been shown to enhance the apoptotic 
response to the chemotherapeutic agent cisplatin in glioma and ovarian carcinoma cell lines 
(Condo et al., 1996) (Lincet et al., 2000). It is also worth noting that p21 was also reported 
to negatively regulate p53-dependant apoptosis in certain systems (Fujiwara et al., 2008).
As was mentioned above, the cells that undergo apoptosis in TCS are arrested in the 
G1 phase.  Other than p21,  the  Cyclin-dependent kinase inhibitor  1B (p27,  Kip1),  also 
known  as  CDKN1B, also  controls  G1-S  phase  transition.  The  p27 gene  has  a  DNA 
sequence similar to other members of the "Cip/Kip" family which include the p21 and p57 
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genes. In addition to this structural similarity the "Cip/Kip" proteins share the functional 
characteristic of being able to bind several different classes of Cyclin and Cdk molecules. 
For example, p27 binds to cyclin D either alone, or when complexed to its catalytic subunit 
CDK4. In doing so, p27 inhibits the catalytic activity of Cdk4, which means that it prevents 
Cdk4 from adding phosphate residues to its principal substrate, the retinoblastoma (pRb) 
protein. Increased levels of the p27 protein typically cause cells to arrest in the G1 phase of 
the cell cycle. Therefore, p27 may be causing the G1 arrest that precedes apoptosis in TCS. 
 
CHAPTER 3: Animal Models of Treacher Collins Syndrome
Animal  models  are  very  important  and useful  in  studying human diseases  and 
identifying  potential  treatments.  There  is  a  wide  variety  of  model  organisms  used  in 
scientific research today, especially  when human experimentation would be unfeasible or 
unethical. Selecting the appropriate model that would serve the study best is very crucial. 
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For a model to be usable to study TCS it has to have a similar head development and is 
easily studied. Homologs of TCOF1 have been identified in mouse (Jabs et al., 1993), dog 
(Haworth et al.,  2001), frog (Gonzales et al.,  2005) and rhesus macaque (Shows et al., 
2006). 
Identification of Canine TCOF1
It is thought that the majority of modern dog breeds have been generated over the 
past 250 years. This suggests that only a small number of loci are controlling most of the 
phenotypic differences (Ostrander et al.,  2000). Such a characteristic makes the dog an 
excellent model system to study the molecular genetics of morphological traits (Haworth et 
al., 2001).
Canine TCOF1 is 4814 bp long and shares 80% identity with the human sequence. 
Dog TCOF1 does not posses an equivalent of exon 10, but contains an extra sequence of 
252 bp between exons 16 and 17. 
The protein coded for by the dog TCOF1 gene was found to share a significant 
homology (71%) with the human’s protein (Haworth et al., 2001). It is 28% serine and 
alanine, exactly like humans. Both the C- and the N- termini are well conserved, sharing 
73% and 81% homology  respectively.  In  dogs  TCOF1 was  found to  be  expressed  in 
neonatal brain, heart, kidney, liver, spine and muscles.
Identification of Frog TCOF1
Homologies between mammals and amphibians TCOF1 was found to be low. For 
example,  mouse  Tcof1 shares  56% and 20% homology  with  human and frog  TCOF1 
(Gonzales et al., 2005). In contrast,  their amino acid compositions are similar in terms of 
predominant  amino  acid  residues  which  include  alanine  (11–15%),  glycine  (4–8%), 
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glutamic acid (7–10%), lysine (11–14%), proline (9–11%), serine (13–15%) and threonine 
(7–8%). Like human, dogs and mice, Xenopus Laevis treacle have an N-terminus rich in 
serine and lysine residues and a C-terminus rich in lysine residues. Close to the center of 
the molecule, there are 11 repeating units of alternating basic and acidic domains. 
To  determine  the  localization  of  frog  treacle,  encoded by  the  cloned  Xenopus 
cDNA,  an  antibody  against  amino  acids  1–307  was  generated  in  chicken.  Indirect 
immunofluorescence staining shows the antigen recognized by this antibody co-localizes 
with nucleolin in the nucleolus of Xenopus Laevis kidney A6 cells (Gonzales et al., 2005). 
Western blot analysis showed that protein is 160 KD. 
Because of the localization of treacle to the nucleolus, it was thought that it may 
have  a  function  in  ribosome biogenesis.  The  cDNA that  encodes  the  Xenopus  laevis 
orthologue  of  TCOF1 was  cloned to  construct  antisense  oligodeoxynucleotides,  which 
decreased  the  Xenopus  TCOF1expression  to  various  levels  when  microinjected 
individually  into  Xenopus oocytes.  The effect  of  treacle  down-regulation  on the 2’-O-
methylation of nucleotide C427 of pre-18S rRNA from Xenopus oocytes was examined. It 
was found that down-regulation of treacle results in decreased methylation of pre-18S. It is 
worth noting that, this was also observed in  Tcof1+/-  mouse embryos on the DBAxCBA 
background which exhibit a lethal phenotype, but it was not observed in  Tcof1+/-  mouse 
embryos on the DBAxBALB/c background, which show milder phenotypes. This suggests 
that hypomethylation of pre-rRNA’s might be contributing to the differences in phenotype 
between these backgrounds.
Murine Model
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The mouse  Tcof1gene is located on chromosome 18 (Jabs et al.,  1993). It has a 
transcript of 4,013 bp, and 1,320 amino acids. It has 74.3% nucleotide identity, 61.5% 
protein identity and 71% similarity to human gene (Dixon et al.,  1997). The homology 
between the gene in humans and in mice is greatest in the C- and in the N-terminal regions 
of the proteins. The repetitive region is less homologous with the exception of the potential 
CKII phophorylation sites which are well conserved (Dixon et al., 1997; Paznekas et al., 
1997). The predicted NLSs at the C-terminus are also well conserved.
Deletion of the  Tcof1  gene in different backgrounds in mice showed variation in 
phenotype  (figure  6).  Although  penetrance  of  genetic  mutations  underlying  Treacher 
Collins Syndrome is known to be very high, inter and intra-familial variations exist (Dixon 
et al., 1994). In severe cases, TCS patients die perinataly due to a compromised airway 
(Edwards et al., 1996). On the other hand, some individuals are so mildly affected that it 
can be extremely difficult to establish an unequivocal clinical diagnosis.
In  fact,  it  is  not  unusual  for  mildly  affected  TCS  patients  to  be  diagnosed 
retrospectively. This usually is brought by the birth of a more severely affected child. This 
suggests that there are more TCS cases than what has been documented, but due to mild 
phenotypes, they went undiagnosed. This variation could be due to genetic background, 
and/or environmental factors.
Chimeric mice that carry a deletion of exon 1 of murine orthologue of TCOF1 have 
been generated (Dixon et al., 2000). Breeding of male chimeras with female C57BL/6 mice 
generated heterozygous offspring that exhibited several features that resembled the human 
disorder. These embryos have hypoplasia of the mandible and abnormalities of the maxilla 
(Dixon et al., 2000). But additional features of the phenotype that were not observed in 
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TCS patients were also observed in these embryos, including absence of the eyes and nasal 
passages and neural tube defects resulting in exencephaly. 
It has been hypothesized that these features may be due either to species-specific 
differences in the function of the human and murine genes or that the severity of the Tcof1 
phenotype depends on the presence of modifying loci elsewhere in the genome. 
Interestingly, although traditional heterozygous Tcof1 KO mice die perinatally on 
the 129/B6 background, conditional KO in which Tcof1 is knocked out in neural crest cells 
are  phenotypically  normal  (Lin  Li  et  al.,  2006).  One  explanation  is  that  other  cell 
populations are also important for craniofacial development. These cell populations may 
expand and compensate for the loss of neural crest cells.
On  a  variety  of  backgrounds,  Tcof1+/- embryos  were  examined  by  gross 
morphologic, histologic and skeletal analyses at different ages, from embryonic day 8.5 
(E8.5) to birth. Each of the different backgrounds or strains that were used generated Tcof1 
+/- embryos that exhibited a highly reproducible,  strain dependant phenotype (Figure ) 
(Dixon et al.,  2004). The lethality of  Tcof1+/-  mice derived from the C57BL/6 has been 
reported  (Dixon  et  al.,  2000).  In  addition,  Tcof1+/-  mice  derived  from  CBA  or  C3H 
backgrounds  exhibited  a  lethal  phenotype  with  perinatal  death  resulting  from  severe 
abnormalities of the nasal complex and neural tube defects that resulted in exencephaly. On 
the other  hand  Tcof1+/-  mice derived from the backgrounds DBA/1 and BALB/c  were 
viable and rarely exhibited exencephaly (Dixon et al., 2004).
Analysis of CBA Tcof1+/- mice embryos showed that this strain exhibit a phenotype 
that very much resembles that of the C57BL/6 strain. Gross morphologic characterization 
showed that both C57BL/6 and CBA- derived Tcof1+/- embryos exhibited a developmental 
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delay of about 0.5 to one gestational day when compared to wild type embryos (Dixon and 
Dixon et al., 2004). 
In addition, exencephaly of the forebrain and the midbrain is another feature 
in common between the two strains. It was present in all C57BL/6 Tcof1+/- embryos and in 
the  vast  majority  of  CBA  Tcof1+/- embryos  (Dixon  and  Dixon  et  al.,  2004).  Ocular 
development was also comparable in the two strains. Anophthalmia (absence of the eyes) 
was observed in all C57BL/6 Tcof1+/- embryos. In CBA Tcof1+/- embryos there was either 
anophthalmia or microphthalmia. 
Interestingly,  skeletal  analyses  revealed  a  distinct  difference  between  the  two 
strains.  While  Tcof1+/- embryos derived from C57BL/6 and CBA backgrounds showed 
many common abnormalities  of  the  craniofacial  and  axial  skeleton,  the  CBA  Tcof1+/-
embryos showed an extra feature, these embryos had delayed ossification of long bones 
and absence of primary center of ossification (Dixon and Dixon 2004). And this feature 
was not present in  Tcof1+/-  embryos derived from the C57BL/6 background. Both strains 
were  also  shown  to  display  absence  of  the  bones  compromising  the  frontal,  parietal, 
interparietal and supraoccipital bones.
Figure 6: Gross morphologic appearance of embryonic day 14.5 wild-type (A) and Tcof1 
heterozygous (Tcof1+/-) embryos derived from different inbred strains as indicated.  B-C: 
DBA/1-  and BALB/c-derived  Tcof1+/- embryos  did not  exhibit  any gross  morphologic 
abnormalities.  D-F: Majority  of  C3H,  C57BL/6,  and CBA  Tcof1+/- embryos  exhibited 
exencephaly. This deformity involved the forebrain and midbrain in the C3H and CBA 
Tcof1+/- embryos and the midbrain in C57BL/6 Tcof1+/- embryos. In addition, C57BL/6 and 
CBA Tcof1+/- embryos exhibited developmental delay and mid-facial hypoplasia.
48
Dixon and Dixon et al., 2004.
The nasal complex development is  poor in  Tcof1+/- embryos derived from both 
strains (Dixon and Dixon et  al.,  2004).  A center cartilaginous mass replaced the nasal 
spectrum, with no signs of nasal passages or olfactory sensory structures. Another skeletal 
abnormality seen in both strains is the fusion of the inter-costal cartilages and ribs. Several 
abnormalities in the form of fusions of cervical and thoracic vertebrae and digit anomalies 
(polydactyly) were also reported to be seen in both strains (Dixon and Dixon et al., 2004). 
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Exencephaly was also seen in  Tcof1+/- embryos on the C3H background. Twenty 
nine  Tcof1+/- embryos on the C3H background were examined three had fully  formed 
cranial vaults and the remaining 26 exhibited exencephaly of the forebrain and midbrain 
with well formed distinct telencephalic vesicles that protruded through the open neural tube 
(Dixon  and  Dixon  et  al.,  2004).  Overall  body  size  of  the  Tcof1+/- C3H  mice  was 
comparable to their wild type littermates. Histological sections showed development of the 
eyes, although they are compressed and abnormally shaped. In contrast to the C57BL/6 and 
CBA  Tcof1+/- embryos,  skeletal  analysis  showed that  C3H  Tcof1+/-  embryos  had well-
developed nasal passages.
DBA/1 Tcof1+/-  embryos showed a moderate craniofacial phenotype. Six out of 48 
Tcof1+/- embryos that were examined displayed exencephaly mainly of the midbrain and to 
a lesser extent the forebrain (Dixon and Dixon et al., 2004). Hypoplasia of the mandible 
was also present in these exencephalic embryos. But in the rest  of the DBA/1  Tcof1+/- 
embryos  appeared  normal  and were  indistinguishable  from their  wild  type  littermates. 
These non-exencephalic DBA/1 Tcof1+/- embryos are viable, fertile and have a normal life 
span. Similar to the DBA/1 Tcof1+/- embryos, BALB/c Tcof1+/- were indistinguishable from 
their  wild  type  littermates.  Except  for  six  embryos  out  of  seventy-six  who  showed 
exencephaly (Dixon and Dixon et al., 2004).
Cross breeding C57BL/ x 129 genetic backgrounds showed a very close phenotype 
to  TCS.  These  Tcof1 +/-  embryos  had  abnormal  maxilla  and  mandible  but  they  also 
exhibited  anophthalmia  and  exencephaly,  which  caused  perinatal  death  (Dixon  et  al., 
2002). This obstacle was resolved by crossing DBA Tcof1+/- mice to C57BL/6 wild type 
animals (Dixon et al., 2006). 
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So variation of phenotype in Tcof1 knockout mice on the different backgrounds 
ranges from severe craniofacial defects and neonatal lethality in C57BL/6 (B6) or CBA/Ca 
and 129 mixed backgrounds to majority phenotypically normal in BALB/c or DBA/1 and 
129 mixed backgreounds. Partial elimination of Tcof1 gene in mouse in a mixed C57BL/6 / 
129  background  is  neonatal  lethal,  which  circumvent  further  detailed  analysis  of  the 
heterozygous  and  homozygous  knockout  mice  on  a  hemogenous  background.  A 
conditional  knockout  mouse  model,  which  might  more  closely  resemble  human  TCS 
phenotype, was generated using the Cre-lox system (Lin Li et al., 2006).
Conventional knockout method results in the inactivation of the targeted gene in all 
tissues  and  development  stages  in  mouse.  In  contrast,  conditional  gene  targeting 
approaches were developed to generate time or tissue-specific knockout of the targeted 
gene. The conditional knockout system can be very useful in studying TCS, to overcome 
that fact that conventional knockout mice are embryonic or neonatal lethal which prevents 
further detailed analysis. In addition, control of gene targeting in a time dependant manner 
allows the analysis of gene function at different developmental stages. Also, the inhibition 
of  gene  expression  in  certain  tissues,  may  give  more  information  about  the  specific 
function of that gene in that certain tissue.
Previous  traditional  Tcof1 knockouts  were  generated  by  replacing exon 1  with 
neomycin-resistance cassette,  which showed that elimination of exon 1 is sufficient for 
disrupting the gene expression (Dixon et  al.,  2000).  A tissue specific  knockout  mouse 
model was generated by the Cre-lox system (Lin Li et al.,  2006). Knockout mice were 
generated with two loxP sites flanking exon 1 of Tcof1 (floxed allele) and then crossed to 
commercially available transgenic mice that express Cre recombinase under the control of 
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the Wnt1 promoter. Wnt1 is expressed in the central nervous system and early neural crest 
cells progenitors (Echelard et al., 1994, Dorsky et al., 1998). 
Due to the major effect that background has on the Tcof1 knockout mice, Wnt1-Cre 
transgenic  mice  were  transferred  to  a  B6  background  from its  orginal  Swiss-Webster 
background. After the background transfer, homozygous floxed Tcof1 mice were mated 
with  Wnt1-Cre  mice  to  generate  conditional  heterozygous  knockout  mice  (Tcof1c+/-). 
Unexpectedly, the Tcof1c+/-  mice are viable, fertile, of normal size and display no physical 
or behavioral abnormalities (Lin Li et al., 2006). This finding suggests that the expression 
of Tcof1 in  other  tissue/cells  or at  an earlier  time is  important  for mouse craniofacial 
development. 
 Tcof1c+/-  that were generated previously (Lin Li et al., 2006) were then mated to 
homozygous  floxed  Tcof1  mice  to  generate  conditional  homozygous  knockout  mice 
(Tcof1c-/-).  Embryos were dissected at  different embryonic days,  because no pups were 
identified at birth. It was found that the morphology of the  Tcof1c-/- is indistinguishable 
from Tcof1c+/- and wild type littermates on embryonic day 8 to 9.5. At E10.5, the Tcof1c-/- 
displayed smaller first and second branchial archs compared to controls. The telencephalon 
appeared larger in homozygotes than controls, which maybe a secondary change due to 
defects in the branchial archs. Defects in craniofacial development started to appear with 
exencephaly  of  the  forebrain  from  E11.5  to  E13.5.  The  maxillary  and  mandible  are 
severely underdeveloped. 
Homozygotes start to die at E12.5, and this is thought to be caused by increased 
abnormality  of  blood vessels  (Lin Li  et  al.,  2006).  There was increased blood vessels 
disruption in the cranial region and often these vessels were abnormally enlarged. 
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Cartilage  development  was  also  assessed in  the conditional  homozygous Tcof1 
knockout by staining with alician blue (Lin Li et al.,  2006).  The majority of Meckel’s 
cartilage,  which is  derived from the first  branchial  arch and provides  the template  for 
mandible development, is not found in the mandible while a portion persists in the malleus 
and incus middle ear ossicles. Later at 13.5, other cartilages in the head region started to 
develop in all controls but only in some of the homozygotes. Limb and spinal cartilages 
were found not to be affected. The manner that cartilages derived from 1st and 2nd branchial 
archs  were  affected,  suggests  that  Tcof1  is  essential  for  these  cartilages  development. 
Although the mouse model can provide a very informative model to study craniofacial 
diseases  due to the similarities  with  humans,  but  it  is  time consuming,  expensive and 
requires a lot of maintenance.
Zebrafish (Danio Rerio) Model
Zebrafish serves as an excellent model for vertebrate developmental studies (Jones 
and Huffman 1957). The landmark study that aimed to understand the development on 
zebrafish was performed in 1938 by Roosen-Runge, and it followed the development of the 
zebrafish embryo from fertilization to hatching, they reported intercellular movements, and 
documented minute changes in cell diameter, viscosity, and surface tension (Vascotto et al., 
1997). 
The zebrafish model provides many advantages in the study of early embryonic 
development including high fecundity,  external and rapid development, transparency of 
embryos, low cost and the ability to knockdown genes of interest. The evolution of the 
head is conserved among vertebrates. Humans and zebrafish diverged ~ 420 million years 
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ago, yet both form the same skeletal cell types, including the neural crest cells (Hall and 
Hanken., 1985).  
Currently, zebrafish is considered an established model for studying craniofacial 
development with several well characterized mutant lines readily available. Some mutant 
lines display craniofacial defects related to those seen in TCS patients. Among those are 
the forkhead box 3 (foxd3), transcription factor ap-2 alpha (tfap2a) and sox9a. Even the 
mechanism of formation of the phenotype in the fox3d mutants is  similar  to the tcof1 
mutants. It is mainly due to failure of a subset of neural crest cells derivatives to undergo 
specification and normal migration (Stewart et al., 2006). Similarly, tcof1 is required of 
survival and migration of certain neural crest cells to the pharyngeal arches in mice (Dixon 
et al., 2000). 
Early developmental stages of zebrafish
For a full understanding of the pathogenesis of any developmental disorder, it is 
important to understand the early stages of development. The major important stages of the 
early development of zebrafish embryo include: the zygote formation, cleavage, blastula, 
gastrulation, segmentation, pharyngula and hatching stages (Kimmel et al., 1995). 
The  zebrafish  zygote  is  about  0.7  mm  in  size  and  this  stage  starts  with  the 
fertilization of the egg and extends for about 40 minutes. The zygote stage is also defined 
by  the  formation  of  what  is  called  the  blastodisc,  which  forms  by  the  migration  of 
cytoplasm toward the animal pole. After the first cleavage the cells starts dividing at about 
15 minutes intervals, defining the second stage which is the cleavage stage (Figure 7). In 
this stage there is synchrony in cell division to the 64 cell stage where a 3 tier blastomere is 
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formed. This is  between 40 minutes to 2 hours post  fertilization (hpf) (Kimmel et  al., 
1995). After that the blastula stage starts, which is marked by the formation of the yolk 
syncytial  layer  (YSL).  This  layer  is  the  result  of  the  fusion  between  the  marginal 
blastomere and the yolk cells. 
The nuclei of the YSL continue dividing but are not accompanied by cytoplasmic 
division.  In  the beginning of  the  late  blastula,  epiboly  starts,  this  is  the  thinning and 
spreading of both the YSL and the blastodisc over the yolk cell. About a third of epiboly is 
completed around 4 hours and 40 minutes post fertilization. 
In the gastrula stage epiboly continues, reaching 75% around 8 hpf (Figure 8). In 
addition,  the morphogenetic  cell  movements of  involution,  convergence,  and extension 
occur, producing the primary germ layers and the embryonic axis (Kimmel et al., 1995). 
Gastrulation ends at around 10 hpf and after that the embryo develops complete epiboly 
and has prominent tail bud and ealy polster. Polster is the hatching gland rudiment at the 
time it underlies the forebrain during the early segmentation period (Kimmel et al., 1995). 
The segmentation stage lasts from 10 1/3 hpf to 24 hpf. In this stage the tail bud 
becomes  prominent,  the  rudiments  of  primary  organs  become visible  and  the  embryo 
elongates. By 48 hours, fins start forming, the otic vesicles also develop and the yolk size 
decreased as the size of the head increase. 
Neural crest cells that are bound to form cartilage begin chondrification. Features of 
lower jaw appear. By 72 hours, the organs are almost completely formed, including jaw, 
gills and fins. 
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Figure 7: Embryos during the cleavage period. Face views, except for B, which shows the 
embryo twisted about the animal-vegetal axis, roughly 45" from the face view. 
A:  Two-cell  stage  (0.75 h).  B: Four-cell  stage  (1 h)  C: Eight-cell  stage  (1.25 h).  D: 
Sixteen-cell stage (1.5 h). E: Thirty-two cell stage (1.75 h). F: Sixty-four cell stage (2 h). 
Scale bar = 250 pm.
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Kimmel at al., 1995.
Figure 8:  Development during gastrula stage. Left side views, except where noted, with 
anterior up and dorsal to the left. A: 50%-epiboly stage (5.25 h). B: Germ ring stage (5.7 
h).  C: Animal pole view of the germ ring stage; the arrow indicates the germ ring.  D: 
Shield stage (6 h). The embryonic shield, marking the dorsal side, is visible as a thickening 
of the germ ring to the left. E: Animal pole view of the shield stage; the arrow indicates the 
embryonic shield. F: 70%-epiboly stage (7.7 h). The anterior axial hypoblast, or prechordal 
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plate (arrow), extends nearly to the animal pole.  G: 70%-epiboly stage, ventral view, but 
tipped slightly forward anteriorly to reveal the now well-delineated axial hypoblast (arrow) 
of the prechordal plate.  H: 75%-epiboly stage (8 h). I:  80%-epiboly stage (8.4 h), dorsal 
view. The arrows indicate the boundaries between axial mesoderm in the midline, and the 
paraxial mesoderm flanking to either side. J: 90%-epiboly stage (9 h). The tail bud (arrow) 
becomes visible in some embryos at this stage. K: 90%-epiboly stage, ventral view. L: Bud 
stage (10 h). The arrow shows the tail bud. Scale bar = 250 pm.
Kimmel et al., 1995.
Creating TCS Zebrafish Model
Zebrafish ortholog of TCOF1 was identified searching with cDNA of  Xenopus 
tcoft  in  GenBank (Holser  et  al.,  2007).  The predicted protein  sequence of  ztcof1 was 
compared to human, mouse and frog orthologs. It was found that the identity between the 
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predicted zebrafish treacle and human’s was 20.8%. This low percentage was also seen in 
tcof1 Xenopus ortholog, which was around 19.2% (Gonzales et al., 2005). In addition, the 
peritive sequence of acidic and basic residues and the C-terminal containing the nuclear 
localizing signals and the nucleolar localizing signal were to be conserved in ztcof1. 
Expression  pattern  of  the  identified  ztcof1  was  also  examined  by  in-situ 
hybridization, and it was found to be expressed widely during development, especially in 
the brain (Holser et al., 2007). This pattern resembled mouse Tcof1 pattern of expression 
during  development.  Expression  in  both  mouse  and  zebrafish  becomes  restricted  in 
branchial  archs,  limb  buds,  and  the  midbrain  region  in  later  stages.  This  uncanny 
resemblance in expression, in the branchail archs and midbrain regions in particular, further 
supported the hypothesis that the identified gene is indeed the zebrafish Tcof1 ortholog. 
To determine in ztcof1 plays a role in craniofacial development in zebrafish, ztcof1 
expression  was  knocked  down  using  morpholinos  (MO).  MO’s  are  short,  synthetic 
antisense  oligonucleotides  designed  to  anneal  to  target  mRNA  sequences  and  block 
translation  by steric  hindrance of  translation  or  splicing machinery (Summerton et  al., 
1999). Two types of MO’s were used in this study to examine the phenotype after ztcof1 
knockdown. One aimed blocked the translation of the mRNA and the other inhibited the 
splicing machinery (Holser et al., 2007).
The splice blocking MO targeted splice donor site in exon 2 of ztcof1, preventing 
its  inclusion  and  creating  a  premature  stop  codon  in  the  resulting  aberrantly  spliced 
transcript. When this MO did not show a phenotype another MO that targeted a donor site 
for exon 3 of ztcof1 was used but also did not show a phenotype. Failure to detect a mutant 
phenotype, maybe attributed to the presence of maternal pre-spliced transcripts, which were 
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found to be abundant at the 8-cell stage using in-situ hybridization. To circumvent this 
problem, a  translation blocking MO was utilized.  This  resulted in  a phenocopy of the 
craniofacial abnormalities seen in TCS mouse models and in patients, including hypoplasia 
of the jaw cartilages (Figure 9) (Holser et al., 2007). Using higher concentration of the MO 
resulted in loss of cartilage elements in some larvae, starting with Meckel’s cartilage, the 
predominant cartilage of the lower jaw. 
For further characterization of ztcof1 role in craniofacial  cartilage development, 
chondrogenesis,  which  is  the  differentiation  of  chondrocytes  from  mesenchyme,  was 
examined by measuring the levels of goosecoid (gsc), a marker for this process. By in-situ 
hybridization, the expression of gsc was shown to be decreased and the migration of the 
chondrocytes constituting the lower jaw was found to be delayed (Holser et al., 2007). In 
addition,  investigation  into  yet  earlier  events,  namely  cranial  crest  patterning  in  the 
branchial archs did not show any difference between ztcof1 MO injected embryos and the 
uninjected ones.
In an attempt to prevent the neuroepithelial apoptosis that results in craniofacial 
hypoplasia, zebrafish embryos were co-injected at 21 hpf with both ztcof1 MO and p53
Figure 9: Translation blocking MO to tcof1 produces hypoplastic craniofacial cartilages as 
seen in 4 dpf zebrafish larvae with alcian blue staining
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Holser et al., 2007.
MO. Embryos showed almost complete rescue of defects that are characteristics of ztcof1 
knockdown (Holser et al., 2007). The co-injected embryos had a morphologically normal 
brain with little or no dark tissue characteristic of ztcof1 morphants. This finding were 
Wildtype
MO 1 mg/ml
MO 2 mg/ml
61
further  confirmed  by  TUNEL assay  that  showed  decreased  apoptosis  in  embryos  co-
injected with both ztcof1 and p53 MO’s compared to un-injected ones (Figure 10). 
Figure 10:  Embryos co-injected with  ztcof1 and  p53 MOs display normal midbrain and 
hindbrain morphology as seen here at 21 hpf (top row).  In addition, cell  death in co-
injected embryos is reduced to near uninjected levels as seen at 21 hpf. 
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CHAPTER 4: P53 Downstream Genes
Introduction 
UI          ztcof1 MO  p53 MO +  p53 MO
                                ztcof1 MO
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The best attempts to rescue the phenotype of TCS were performed by inhibiting 
tumor suppressor p53 in Tcof1 heterozygous mice and in zebrafish by co-injecting p53 
morpholinos along with that of ztcof. Thus, interrupting the apoptosis pathway of TCS 
proved to be sufficient in preventing the onset of the disease in these two animal models. 
However, the loss of p53 in mice resulted in tumor formation and this limits the potential 
of  using this  rescue in  preventing onset  TCS in humans.  Therefore,  it  is  important  to 
identify other members of the apoptotic pathway which if lost, will not cause cancer. 
P21 is a very strong candidate for many reasons described earlier in chapter 2. In 
addition, p21 homozygous knockout mice do not develop tumors (Deng C et al.,  1995) 
which  overcome the obstacle  of  tumor formation  when p53 is  knocked out.  The pro-
apoptotic protein, Bnip3l, is another strong candidate that appeared to be upregulated in 
TCOF1 knockdown mouse  neuroblastoma cell  line  (Mogass  et  al.,  2004)  and may be 
down-stream of p53 in the apoptosis pathway. The cell cycle arrest in G1 phase has been 
observed in TCS models (Dixon et al.,  2008; Lin Li et al.,  2006), which makes p27 a 
potential member of the pathway. Therefore, the level of expression of these three genes 
was examined by in-situ hybridization, in ztcof1 morpholino injected embryos. 
Materials and Methods 
Zebrafish Culture and Maintenance 
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Adult fish were maintained at approximately 28˚C on a 14 hour/10 hour light/dark 
cycle.  Wild  type  strains  (AB strain  or  AB/TU)  were  used  for  all  experiments  unless 
otherwise indicated. Embryos were incubated at 28˚C until desired stage was reached. 
Probe Preparation
Approximately 5 µg of the following plasmids were linearized using the restriction 
enzyme EcoRI and approximately 1 µg served as templates for transcription reaction using 
the indicated RNA polymerase: pBS-IISK-p27 – T7 RNA polymerase, pBluescript  SK-
Bnip3l – T7 RNA polymerase. P21 which was purchased in a pSPORT1 vector (ZFIN) did 
not contain an RNA polymerase promoter. Therefore, the p21 plasmid was digested with 
EcoRI and the cDNA was amplified with PCR by a T3 promoter coded in the 3’ primer. 
The digested plasmids and PCR product were purified for the transcription reaction with 
GeneClean purification kit (Qbiogene). Probes were then diluted 1:100 to 1:200 in [50% 
formamide, 5x SSC, 50 mg/ml heparin, 500 mg/ml tRNA, 0.1% Tween 20, 9 mM citric 
acid]. 
In situ   Protocol 
Embryos staged as described by Kimmel et al. (1993) were fixed 24, 48 and 72 
hours in 4% paraformaldehyde in 1XPBS (phosphate-buffered saline), hand dechorionated 
and  dehydrated  overnight  in  methanol  at  -20°C.  Then  the  embryos  were  rehydrated 
stepwise in methanol/PBT and finally put back in 100% PBT (1´ PBS 0.1% Tween 20). 
Embryos older than 24 hours were treated with proteinase K (20 mg/ml in PBT) 1 minute 
at  room temperature  for  every  hour  of  embryo  age.  Prpteinase  K  was  aspirated  and 
embryos were post-fixed with 4% PFA in 1xPBS for 20 minutes and then washed several 
times with 1xPBT 5 times for 5 minutes each. The embryos were prehybridized at least 1 
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hour at 65°C in hybridization buffer [50% formamide, 5x SSC, 50 mg/ml heparin, 500 mg/
ml tRNA, 0.1% Tween 20, 9 mM citric acid]. The hybridization was done in the same 
buffer containing 50 ng to 100 ng of probe overnight at 70°C. Then the embryos were 
washed at 65°C for 10 minutes in [75% hybridization buffer, 25% 2x SSC], 10 minutes in 
[50% hybridization buffer,  50% 2x SSC],  10 minutes in [25% hybridization mix,  75% 
2xSSC], 10 minutes in 2x SSC, 2 times 20 minutes in 0.2x SSC. Further washes were 
performed at room temperature for 5 minutes in [75% 0.2x SSC, 25% PBT], 5 minutes in 
[50% 0.2x SSC, 50% PBT], 5 minutes in [25% 0.2x SSC, 75% PBT], 5 minutes in PBT, 
and then 1 hour in [PBT with 2 mg/ml BSA (bovine serum albumin), 2% sheep serum]. 
Then  the  embryos  were  incubated  overnight  at  4°C  with  the  preabsorbed 
alkalinephosphatase- coupled anti-digoxigenin antiserum (described in  Boehringer)  at  a 
1/10,000 dilution in a PBT buffer containing 2 mg/ml BSA, 2% sheep serum. Finally the 
embryos were washed 6 times for 15 minutes each in PBT at room temperature. Detection 
was performed in alkaline phosphatase reaction buffer described in the Boehringer. When 
the color was developed, the reaction was stopped in 1x PBT and embryos were dehydrated 
and cleared in MeOH overnight. The embryos were then rehydrated in MeOH/PBT series 
and equilibrated in 50% glycerol in 1 X PBS for viewing and photographing. 
Morpholino
Ztcof1  morpholino  that  was  used  in  this  study  has  been  previously  described 
(Holser, 2007).
Results
Examining the levels of expression of the p27 gene in zebrafish embryos that were 
injected with ztcof1 MO showed no difference from the ones that were injected with the 
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Mismatch (MM) (Figure 11). However,  p21,  which is  one of the major transcriptional 
targets of p53, and is known to be responsible for causing G1 phase cell cycle arrest in 
response to a variety of stimuli was found to be upregulated in ztcof1 MO injected embryos 
compared to MM injected ones. This was observed in the 24 (data not shown), 48 and 72 
hpf (figure 12). Bnip3l, which is also a transcriptional target of p53, was not found to be 
upregulated in ztcof1 MO injected embryos as compared to the embryos injected with the 
MM (figure 13).
Discussion
p27 is known to bind to cyclin D either alone, or when complexed to its catalytic 
subunit CDK4. In doing so, p27 inhibits the catalytic activity of Cdk4, which means that it 
prevents Cdk4 from adding phosphate residues to its principal substrate, the retinoblastoma 
(pRb) protein. This inhibits the dissociation of E2F-1, which is a transcription factor, from 
pRb and hence from mediating the trans-activation of E2F-1 target genes that facilitate the 
G1/S transition. Therefore, increased levels of the p27 protein typically cause cells to arrest 
in the G1 phase of the cell cycle. However, the in-situ hybridization showed no significant 
increase in p27 in MO injected embryos when compared to one injected with the MM. This 
indicates that, it  could be another G1/S checkpoint that causes the G1 phase cell  cycle 
arrest observed in TCS.
The CDK inhibitor p21 was upregulated in embryos that were injected with ztcof1 
MO compared to embryos injected with the MM. This result is expected because p53 is 
stabilized when ztcof1 is knocked down and as was mentioned previously, p53 promotes 
transcriptional activation of p21. The exact role of p21 in apoptosis remains unclear, but 
the G1 phase cell cycle arrest must be a very important part of it. It would be interesting to 
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investigate the potential of rescuing the onset of TCS in any of the models by inhibiting the 
expression of p21.
Bnip3l, which is a proapoptotic protein that has a p53 binding sequence in it’s gene, 
was not found to be upregulated in embryos injected with the MO, compared to the ones 
injected with the MM. Therefore,  it  is more likely that the apoptosis does not involve 
Bnip3l.
Future work
In summary, when Tcof1 is reduced, ribosome biogenesis is affected and this leads 
to the activation of p53 through its stabilization. In turn, p53 promotes G1 phase cell cycle 
arrest and ultimately apoptosis. The inhibition of this apoptosis pathway, by inhibiting p53 
expression, proved to be sufficient in preventing the onset of TCS in the mouse model 
(Dixon et al., 2008). The fact that most mice in this rescue developed tumors within 3 to 6 
months limits the potential of using it when treating TCS in humans. Therefore, further 
studies should be performed to find other members in this pathway and try to rescue the 
phenotype using this knowledge.
When ribosome biogenesis is impaired, L11 diffuse into the nucleoplasm where it 
sequesters  HDM2,  ultimately  stabilizing  p53  (Lohrum  et  al.,  2003).  This  could  be 
occurring upstream of p53-mediated cell cycle arrest and apoptosis seen in TCS. A rescue 
experiment could be performed by the inhibition of the expression of L11. This should be 
first investigated using the zebrafish model, by the co-injection of ztcof1 MO and L11 MO 
followed  by  TUNEL  assay  to  test  if  the  knockdown  of  L11  would  prevent  the 
neuroepithelial apoptosis and rescue phenotype.
After seeing an increased level of expression of the Cdk inhibitor, p21, following 
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the knock down of ztcof1 in zebrafish embryos, the possibility of preventing the onset of 
TCS by blocking p21 is raised. The most informative and suitable model to use for this 
rescue is TCS mouse model obtained by breeding DBA Tcof1+/-  mice and C57BL/6 wild 
type  mice  to  generate  mixed DBA x C57BL/6  F1 progeny (Dixon,  J  et  al.,  2006).  F1 
progeny of  DBA Tcof1+/-  mice bred with C57BL/6 p21 +/-  to generate compound Tcof1+/- 
p21 +/- mice, will be compared to DBA Tcof1+/- mice bred with C57BL/6 wild type mice as 
controls. Morphology of the head can then be assessed. In addition, to evaluate the efficacy 
of  p21  inhibition  in  preventing  the  pathogenesis  of  TCS,  the  segregated  streams  of 
migrating cranial neural crest cells can be examined using in-situ hybridization detecting 
Sox10 (at E9.0) which is a cranial neural crest marker (reviewed in Kelsh RN et al., 2006). 
If inhibition of p21 should prevent the pathogenesis of TCS,  in-situ hybridization would 
show the discrete segregated migrating streams of neural crest cells resembling wild type. 
Another rescue experiment can be performed using the zebrafish model by the co-injection 
of ztcof1 and p21 morpholinos followed by TUNEL assay to test if the knockdown of p21 
will prevent apoptosis.
The microarray study (Mogass et al., 2004) revealed a number of genes that were 
found to  be  positively  or  negatively  correlated  with  TCOF1 expression.  These  results 
should be confirmed with RT-PCR which would also reveal the extent of that correlation. 
Strongly  correlated  genes  should  then  be  investigated  according  to  their  functional 
classification, as either cell cycle genes, metabolism genes... etc. 
For  example,  Rasa1,  a known cell  cycle  protein,  was found to be coordinately 
regulated with Tcof1 expression. Rasa1 is known to reduce p38 MapK activity through the 
promotion of GDP-Ras so less phosphate is available for phosphorylation. P38 MapK is a 
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member of mitogen-activated protein kinases and is  known to activate p53 by directly 
phosphorylating the protein. Therefore, there is a possibility that L11 protein is promoting 
p53 stabilization while increased levels of p38 MapK is promoting activation of the protein 
by directly  phophorylating it,  when Tcof1 is  knocked down.  The levels  of  p38 Mapk 
protein should be tested by Western Blot in the TCOF1 knocked down neuroblastoma cell 
line. Due to decreased levels of Rasa1, it is expected that protein levels of p38 Mapk be 
increased in the TCOF1 knocked down cell line. 
If  levels  of  p38  MapK were  found  to  be  elevated,  it  would  be  interesting  to 
investigate the potential of inhibiting the expression of this protein to prevent apoptosis. 
Although previous experiments to inhibit  the neuroepithelial apoptosis by knocking out 
p53 resulted in tumors, inhibiting the phosphorylation of p53 by p38 MapK would not 
affect phophorylation mediated by kinases implicated in the genome integrity checkpoints. 
This would overcome the obstacle of tumor formation when p53 in knocked out. Another 
protein called fatty acid binding protein-3 (Fabp3) was found to be negatively correlated 
with Tcof1 expression. Fabp3 is also called mammary  derived growth inhibitor (MDGI) 
due to its potential role as an anti-tumor protein. Due to abnormally increased levels of this 
protein when TCOF1 is knocked down, it is possible that it may be mediating apoptosis 
seen in TCS. Therefore, it would be interesting to inhibit the expression of this protein in 
the TCOF1 KD neuroblastoma cell line using siRNA, and then assess apoptosis by TUNEL 
assay and see if the inhibition reduces apoptosis.
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Figure 11: p27 expression was found to be the same in the MO injected embryos and MM 
in the 48 and 72 hpf. a and c show MM injected embryos at 48 and 72 hpf respectively. b 
and d show MO injected embryos at 48 and 72 hpf respectively.
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Figure 12: The level of expression of p21 was found to be increased in embryos that were 
injected with the MO compared to the ones injected with the MM at both the 48 and 72 hpf 
stages.  a and c show MM injected embryos at 48 and 72 hpf respectively. b and d show 
MO injected embryos at 48 and 72 hpf respectively
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Figure 13: Bnip3l expression was found to be the same in the MO injected embryos and 
MM in the 48 and 72 hpf. a and c show MM injected embryos at 48 and 72 hpf 
respectively. b and d show MO injected embryos at 48 and 72 hpf respectively.
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